294 related articles for article (PubMed ID: 9167914)
1. The insulin resistance syndrome.
Smolar EN
Compr Ther; 1997 Apr; 23(4):237-43. PubMed ID: 9167914
[No Abstract] [Full Text] [Related]
2. Insulin resistance: the clinical spectrum.
Mantzoros CS; Flier JS
Adv Endocrinol Metab; 1995; 6():193-232. PubMed ID: 7671097
[No Abstract] [Full Text] [Related]
3. Insulin resistance in patients with polycystic ovary syndrome.
Schröder AK; Tauchert S; Ortmann O; Diedrich K; Weiss JM
Ann Med; 2004; 36(6):426-39. PubMed ID: 15513294
[TBL] [Abstract][Full Text] [Related]
4. [Metabolic syndrome and fatal quartet].
Standl E
Internist (Berl); 1996 Jul; 37(7):698-704. PubMed ID: 8766263
[No Abstract] [Full Text] [Related]
5. Polycystic ovarian syndrome: the next cardiovascular dilemma in women?
Srikanthan P; Korenman S; Davis S
Endocrinol Metab Clin North Am; 2006 Sep; 35(3):611-31, x. PubMed ID: 16959589
[TBL] [Abstract][Full Text] [Related]
6. Ovarian function and obesity--interrelationship, impact on women's reproductive lifespan and treatment options.
Rachoń D; Teede H
Mol Cell Endocrinol; 2010 Mar; 316(2):172-9. PubMed ID: 19818376
[TBL] [Abstract][Full Text] [Related]
7. Type 2 diabetes and the polycystic ovary syndrome.
Pelusi B; Gambineri A; Pasquali R
Minerva Ginecol; 2004 Feb; 56(1):41-51. PubMed ID: 14973409
[TBL] [Abstract][Full Text] [Related]
8. Polycystic ovary syndrome and type 2 diabetes mellitus.
De Leo V; Musacchio MC; Morgante G; La Marca A; Petraglia F
Minerva Ginecol; 2004 Feb; 56(1):53-62. PubMed ID: 14973410
[TBL] [Abstract][Full Text] [Related]
9. [Long-term risks of polycystic ovaries syndrome].
Lefebvre P; Raingeard I; Renard E; Bringer J
Gynecol Obstet Fertil; 2004 Mar; 32(3):193-8. PubMed ID: 15123116
[TBL] [Abstract][Full Text] [Related]
10. Acupuncture: is it effective for treatment of insulin resistance?
Liang F; Koya D
Diabetes Obes Metab; 2010 Jul; 12(7):555-69. PubMed ID: 20590731
[TBL] [Abstract][Full Text] [Related]
11. Polycystic ovary syndrome, diabetes and cardiovascular disease: risks and risk factors.
Lakhani K; Prelevic GM; Seifalian AM; Atiomo WU; Hardiman P
J Obstet Gynaecol; 2004 Sep; 24(6):613-21. PubMed ID: 16147598
[TBL] [Abstract][Full Text] [Related]
12. [Obesity--significance in adolescence and for reproduction].
Wolf AS; Sterzik K
Zentralbl Gynakol; 1998; 120(5):210-22. PubMed ID: 9629628
[TBL] [Abstract][Full Text] [Related]
13. [Management of diabetes in cardiac diseases].
Işik S; Delibaşi T; Berker D; Aydin Y; Güler S
Anadolu Kardiyol Derg; 2009 Jun; 9(3):238-47. PubMed ID: 19520659
[TBL] [Abstract][Full Text] [Related]
14. [Polycystic ovary syndrome and insulin resistance].
Puder J; Pralong F
Rev Med Suisse; 2009 Apr; 5(198):779-82. PubMed ID: 19418980
[TBL] [Abstract][Full Text] [Related]
15. Exercise and the metabolic syndrome.
Eriksson J; Taimela S; Koivisto VA
Diabetologia; 1997 Feb; 40(2):125-35. PubMed ID: 9049471
[No Abstract] [Full Text] [Related]
16. [Polycystic ovary syndrome: significance of insulin resistance].
Grott S; Algenstaedt P
Dtsch Med Wochenschr; 2003 Oct; 128(43):2261-6. PubMed ID: 14574641
[No Abstract] [Full Text] [Related]
17. Gut hormones, obesity, polycystic ovarian syndrome, malignancy, and lipodystrophy syndromes.
Bloomgarden ZT
Diabetes Care; 2007 Jul; 30(7):1934-9. PubMed ID: 17596508
[No Abstract] [Full Text] [Related]
18. The clinical implications of insulin resistance.
Peters AL
Am J Manag Care; 2000 Aug; 6(13 Suppl):S668-74; discussion S675-81. PubMed ID: 11183420
[TBL] [Abstract][Full Text] [Related]
19. Role of lifestyle modification in the management of polycystic ovary syndrome.
Hoeger KM
Best Pract Res Clin Endocrinol Metab; 2006 Jun; 20(2):293-310. PubMed ID: 16772159
[TBL] [Abstract][Full Text] [Related]
20. Type 2 diabetes and polycystic ovary syndrome.
Legro RS
Fertil Steril; 2006 Jul; 86 Suppl 1():S16-7. PubMed ID: 16798276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
